Project Supervisor - Bioanalysis
About the job
- A college diploma in science.
- Bilingual English proficiency, including oral and written communication on often technical subjects and the ability to write procedures and technical reports.
- Plan, organize, manage, and monitor the activities and operations of the work unit according to the area of expertise, work plan, and divisional or organizational needs to achieve planned results.
- Prepare, review, and/or approve all documents related to assigned projects.
- Manage resources assigned to projects to ensure that client timelines are met.
- Provide technical expertise to laboratory personnel.
- Interact daily with the technical and scientific team and management to establish assignment priorities.
- Communicate information needed to keep the team and organization informed about the team's work plan, projects, processes, results, actions taken, and recommendations made to meet needs.
- Inform internal and external clients about the division's areas of expertise by assessing needs and conducting analyses and follow-ups.
- Represent the work unit internally and externally for consultation, information, and/or referrals.
- Ensure that team members have access to training.
- Contribute, as needed, to developing the work unit budget, ensuring that it is respected, monitoring the budget for stakeholders, and recommending measures to achieve planned results.
- Participate in developing and analyzing performance-indicator systems for the work unit according to established objectives.
- Identify opportunities to improve the department's work plan and processes.
- Determine, as needed, the measures required to improve efficiency.
- Perform activities in accordance with the company's and division's policies, standard operating procedures, and operating guides, and perform other tasks assigned by management.
Syneos Health® est une organisation de premier plan, entièrement intégrée, spécialisée dans les services en sciences de la vie, conçue pour accélérer le succès de ses clients. Nous collaborons avec des innovateurs à chaque étape du continuum du développement et de la commercialisation des médicaments, en les aidant à naviguer dans la complexité, à anticiper le changement et à accélérer leurs progrès.
Les membres de notre équipe Clinical Solutions adoptent une approche axée sur le développement des médicaments, en mettant à profit leurs années d’expérience et leur expertise approfondie pour comprendre pleinement les besoins des clients et les refléter dans les solutions que nous concevons.
Que vous nous rejoigniez dans le cadre d’un partenariat de type Functional Service Provider ou dans un environnement full-service, vous collaborerez avec des professionnels passionnés par la résolution de problèmes, en innovant en équipe pour aider nos clients à atteindre leurs objectifs. Nous sommes agiles et animés par la volonté de délivrer — les uns pour les autres, pour nos clients et, surtout, pour les patients qui en ont besoin.
Découvrez ce que vos 25 000 futurs collègues savent déjà :
Pourquoi Syneos Health
• Nous sommes passionnés par le développement de nos collaborateurs, grâce à des opportunités d’évolution de carrière, un management de proximité engagé et bienveillant, des formations techniques et thérapeutiques, ainsi que des programmes de reconnaissance entre pairs et de rémunération globale.
• Nous nous engageons à bâtir une culture inclusive, où chacun peut être pleinement lui-même. Au cœur de cette démarche se trouve notre raison d’être — *Driven to Deliver* — qui reflète la passion de nos collaborateurs à proposer chaque jour des solutions capables d’avoir un impact significatif sur la vie des patients.
• Nous construisons continuellement l’entreprise dans laquelle nous souhaitons tous travailler et avec laquelle nos clients souhaitent collaborer. Pourquoi ? Parce que nous savons qu’en réunissant des talents du monde entier, nous pouvons façonner l’avenir des soins de santé, générer un impact pour nos clients et accélérer les progrès au bénéfice des patients.
Job Responsibilities
Venez découvrir ce que nos 25 000 employés savent déjà : le travail accompli ici a des répercussions partout. Nous sommes un chef de file de l’industrie biopharmaceutique en constante évolution, ce qui signifie que vous aurez d’innombrables occasions de travailler avec des experts du monde entier et vous obtiendrez la carrière dont vous avez toujours rêvé.
En tant que membre de l’équipe Syneos Health, vous participerez à l’obtention de résultats dans un objectif plus que valorisant : améliorer la vie de patients partout dans le monde. Pour nous, un patient n’est pas un numéro, ils sont notre famille, nos amis et nos voisins.
Pourquoi choisir Syneos Health
• #SyneosHealthLife représente notre engagement envers notre culture du soi total, au sein de laquelle tous et chacun peut être authentiques. Notre culture du soi total est notre fondement global; nous reconnaissons que la contribution unique de chaque personne fait toute la différence.
• Nous croyons que notre réussite provient directement des personnes qui l’initient, vous! Nous apprécions votre engagement envers nos clients et nos patients, nous voulons donc nous engager envers vous en vous offrant un programme d’avantages sociaux complet comprenant une couverture pour tous les aspects médicaux, physiques, psychologiques et financiers.
• Nous travaillons sans relâche à bâtir l’entreprise pour laquelle nous rêvons tous de travailler et avec laquelle nos clients veulent travailler. Pourquoi? Parce que lorsque nous regroupons diverses opinions, expériences, cultures et perspectives, nous sommes en mesure de créer un endroit où chacun se sent à sa place.
Le scientifique analytique I (Immunochimie) est responsable d’offrir son soutien pour l’analyse courante d’échantillons tout en se familiarisant avec les procédures et les MON en vigueur au laboratoire.
Le titulaire de ce poste est responsable de coordonner toute la gamme des activités liées à la portion bioanalytique des projets afin de répondre aux attentes des clients internes et externes, et de mobiliser et de guider les membres de l’équipe.
RESPONSABILITÉS DU POSTE
• Planifier, organiser, gérer et surveiller les activités/opérations de l’unité de travail selon le champ d’expertise, le plan de travail et les besoins de la division et/ou l’organisation afin d’atteindre les résultats prévus.
• Préparer, réviser et/ou approuver tous les documents liés aux projets qui lui sont confiés.
• Gérer les ressources attribuées aux projets afin de s’assurer que les échéanciers de client sont respectés.
• Offrir une expertise technique au personnel du laboratoire.
• Interagir quotidiennement avec l’équipe technique/ scientifique et la direction afin d’établir les priorités des attributions.
• Communiquer l’information nécessaire afin de tenir son équipe ainsi que l’organisation au courant du plan de travail de son équipe, des projets, processus, résultats, mesures prises et recommandations faites pour satisfaire aux besoins.
• Informer les clients internes/externes des différents secteurs d’expertise de la division en évaluant les besoins et en effectuant des analyses et des suivis.
• Représenter son unité de travail, à l’interne et à l’externe, pour ce qui est de la consultation et/ou de l’information et/ou des références.
• S’assurer que les membres de son équipe ont accès à de la formation.
• Peut être appelé à contribuer à l’élaboration du budget de l’unité de travail et à s’assurer de son respect, à effectuer un suivi du budget pour les intervenants et à recommander des mesures afin d’atteindre les résultats prévus.
• Participer à l’élaboration et à l’analyse de systèmes d’indicateur de rendement de son unité de travail selon les objectifs établis.
• Repérer les possibilités d’amélioration pour le plan de travail et les processus du service.
• Déterminer, au besoin, les mesures nécessaires afin d’améliorer l’efficience.
• Responsable d’effectuer les activités conformément aux politiques, modes opératoires normalisés et guides d’opération en vigueur de l’entreprise et de la division, et d’effectuer d’autres tâches assignées par la direction.
EXIGENCES DE QUALIFICATION
• Diplôme d’études collégiales en sciences.
• Niveau d’anglais : le bilinguisme requis inclut la communication orale et écrite sur des sujets souvent techniques, et la rédaction de procédures et de rapports techniques.
Avertissement :
La liste des activités, des tâches et des responsabilités présentée dans cette description de poste n’est pas exhaustive. L’Entreprise, à sa seule discrétion et sans préavis, pourrait attribuer d’autres activités, tâches ou responsabilités au poste. Des expériences, des compétences et/ou des études équivalentes seront également prises en compte; les qualifications du titulaire de ce poste pourraient donc être différentes de celles énumérées dans la description de poste. L’Entreprise, à sa seule discrétion, établira ce qui constitue un équivalent aux qualifications décrites précédemment. De plus, rien dans la présente ne doit être interprété comme créant un contrat de travail. Occasionnellement, les compétences/expériences nécessaires pour un travail sont exprimées en termes brefs. Tout langage contenu dans la présente vise à satisfaire pleinement à toutes les obligations imposées par la législation de chaque pays dans lequel l’Entreprise exerce ses activités, y compris la mise en application du document « EU Equality Directive », relativement au recrutement et au travail de ses employés. L’Entreprise s’engage à respecter la loi Americans with Disabilities Act, y compris la disposition sur les accommodements raisonnables, s’il y a lieu, afin d’aider les employés ou les candidats à effectuer les tâches principales de leur poste.
Découvrez Syneos Health
Au cours des cinq dernières années, nous avons collaboré sur 94 % de tous les nouveaux médicaments approuvés par la FDA, 95 % des produits autorisés par l’EMA, ainsi que sur plus de 200 études menées sur 73 000 sites et impliquant plus de 675 000 patients.
Quel que soit votre rôle, vous ferez preuve d’initiative et remettrez en question le statu quo à nos côtés, dans un environnement hautement compétitif et en constante évolution. Pour en savoir plus sur Syneos Health :
[http://www.syneoshealth.com](http://www.syneoshealth.com)
Informations complémentaires
Les tâches, fonctions et responsabilités décrites dans cette fiche de poste ne sont pas exhaustives. L’entreprise se réserve le droit, à sa seule discrétion et sans préavis, d’assigner d’autres tâches, fonctions et responsabilités. Une expérience, des compétences et/ou une formation équivalentes seront également prises en compte ; par conséquent, les qualifications des titulaires du poste peuvent différer de celles indiquées dans la présente description. L’entreprise déterminera, à sa seule discrétion, ce qui constitue une équivalence aux qualifications mentionnées ci-dessus.
Par ailleurs, aucune disposition du présent document ne doit être interprétée comme créant un contrat de travail. Les compétences et expériences requises peuvent parfois être décrites de manière succincte. Le contenu du présent document vise à respecter pleinement les obligations légales applicables dans chaque pays où l’entreprise opère, y compris la mise en œuvre de la directive européenne sur l’égalité en matière de recrutement et d’emploi.
L’entreprise s’engage à respecter l’Americans with Disabilities Act (ADA), notamment en fournissant des aménagements raisonnables, lorsque cela est approprié, afin d’aider les employés ou les candidats à exercer les fonctions essentielles du poste.
About the company
Syneos Health provides end-to-end biopharmaceutical solutions across the clinical-to-commercial spectrum. It helps biopharma companies, healthcare organizations, and investors by offering specialized expertise, insights, and technology-enabled services to move therapies faster to patients. Its offerings include Kinetic, a modern omnichannel customer engagement platform that uses targeting and analytics to coordinate nationwide healthcare communications, and Syneos One, an asset development approach that aligns strategy and execution from early concept through commercialization. The company uses AI and advanced tech to improve performance and reduce risk in drug development and market delivery. Its goal is to be a trusted partner that accelerates therapy development and delivery by combining scientific know-how with integrated, data-driven services.
Company Size
10,001+
Company Stage
IPO
Headquarters
Morrisville, North Carolina
Founded
1985
Get referred to Syneos Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- KAI partnership on April 30, 2026 expands commercial intelligence for U.S. pharma launches.
- Syneos says Causaly cut study-design insight time roughly 50% in 2026.
- Databricks reduced source-data review from days to hours, speeding trial interventions.
What critics are saying
- March 31, 2026 Kempen discovery keeps securities-fraud claims alive over backlog reporting.
- Syneos Italy announced 49 layoffs on March 25, 2026, signaling operating pressure.
- A sustained data-integrity finding in Kempen would damage sponsor trust and trigger defections.
What makes Syneos Health unique
- Syneos combines clinical development and commercialization under one roof, unlike pure-play CROs.
- August 18, 2026 AI stack spans Causaly, Databricks, and Microsoft across workflows.
- More than 280 Microsoft Copilot agents give Syneos broad internal automation depth.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- 401(k) Company Match
- Employee Stock Purchase Plan
- Flexible Work Hours
- Paid Vacation
- Paid Sick Leave
- Remote Work Options
Company News
Optum and Syneos Health partner to advance an adaptive Clinical Development model. Partnership Will Transform How Clinical Development is Designed and Executed MORRISVILLE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) - Syneos Health(R) today announced a partnership with Optum to build a more adaptive and connected model for clinical development, helping biopharmaceutical companies deliver promising therapies to patients sooner. The collaboration will bring together Optum's healthcare industry knowledge, specialized expertise and AI resources with Syneos Health's clinical development expertise, global trial operations and technology solutions. The resulting model is designed to strengthen development strategies and execute more precise, efficient trials by improving recruitment and trial performance, reducing operational complexity and enhancing predictability across development timelines and costs. Under the agreement, Syneos Health and Optum will partner closely in the development of: * Adaptive clinical development planning to enable development teams to simulate trial scenarios, evaluate protocol assumptions, identify possible risks and assess interventions before and during trial implementation. * Patient, site and investigator access to help clinical trial sponsors more easily identify eligible patient populations to expand patient access and optimize locations so trials can begin faster. Syneos Health will be Optum's preferred partner for the development of their site management organization (SMO). * Data, technology and governance infrastructure to responsibly scale these improvements while maintaining rigorous standards for scientific validation, privacy, evidence traceability and human oversight. "Clinical development is at an inflection point. The future belongs to organizations that can connect data, human expertise and AI technology to make better decisions faster," said Costa Panagos, Chief Executive Officer of Syneos Health. "Our collaboration with Optum brings deep healthcare expertise that can help improve trial design and implementation with greater precision and predictability." "Clinical research is one of the most complex and data-intensive activities in healthcare, yet necessary connections are fragmented all too often," said Sandeep Dadlani, Chief Executive Officer of Optum Insight. "By connecting our responsible use of technology and network with Syneos Health's global clinical development capabilities, we can make the health system work better for everyone." This announcement builds on Syneos Health's broader commitment to shape the future of clinical development. As part of its AI ecosystem, the Company continues to invest in technologies and collaborations that enhance decision-making, streamline execution and unlock new value from clinical and real-world data. Recent initiatives have included expanding agentic solutions that connect insights, workflows and expertise across operations. About Syneos Health Syneos Health(R) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, commercial and real world insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share diverse insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients. Syneos Health is powered by an authentic, inclusive and high-performance culture that cares for colleagues, customers, patients, communities and the environment. About Optum Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 310,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group (NYSE: UNH). For more information, visit www.optum.com. Press/Media Contact: Meg Byers Director, External Communications [email protected]
Teletrac Navman appoints Sara Epstein to senior leadership role. Reading Time: 2 mins read Teletrac Navman has appointed Sara Epstein as chief legal and administrative officer as the connected mobility business enters its next phase of growth. Epstein brings more than 20 years of legal and executive leadership experience across sectors including healthcare, life sciences, pharmacy and logistics. She will oversee Teletrac Navman's legal, compliance, data privacy and governance functions, along with People and Culture and Health and Safety. Epstein was previously chief legal officer at pharmacy benefits company RxBenefits and executive vice president and deputy general counsel at Syneos Health, where she led a global team responsible for legal and privacy services. She has also held senior legal roles at Cotiviti Holdings and BlueLinx Holdings and was an associate at international law firm Jones Day. Teletrac Navman President and chief executive Alain Samaha says Epstein's experience will support the company's strategic and growth plans. "Sara brings a powerful combination of legal acumen, business judgment and executive leadership that will help accelerate our strategic initiatives and support our long-term growth," Samaha says. "Her experience leading global teams and navigating complex business environments will be instrumental as we continue to drive innovation, strengthen our customer relationships and execute on our growth ambitions. We're thrilled to welcome her to the team." The appointment follows Teletrac Navman's acquisition by Respida Capital earlier this year and a series of product developments, including the launch of Energy Hub within its TN360 fleet management platform and the company's Electronic Braking Performance Monitoring System. "I'm excited to join Teletrac Navman at such an important time in the company's evolution," Epstein says. "The organisation has a strong foundation, a talented global team, and a clear vision for growth. I look forward to working across the business to support our strategic priorities and contribute to the next chapter of Teletrac Navman's success." Epstein holds a Juris Doctor from Tulane University Law School and a bachelor's degree from Tufts University.
Madhuri Raya joins Syneos Health as Global Head, AI & Engineering and Technology Capability Center. Hyderabad, Telangana, India, August 2026 - Syneos Health has appointed Madhuri Raya as Global Head, AI & Engineering and Technology Capability Center, strengthening its technology leadership as the organisation accelerates its AI-enabled strategy. In her new mandate, Raya will focus on scaling engineering capabilities behind Syneos Health's growing AI ecosystem and helping translate technology innovation into practical solutions for biopharmaceutical development. Raya brings more than two decades of experience across software engineering, product engineering, cloud-native technologies, AI/ML-enabled solutions and global engineering leadership. She joins Syneos Health after a long tenure with Optum, where she most recently served as Vice President of Software Engineering. During more than eight years with the organisation, she progressed through senior technology leadership positions, including Director of Product Engineering and Senior Director - Product Engineering. Before Optum, Raya spent more than five years with UnitedHealth Group, serving as Engineering Manager and subsequently Senior Engineering Manager. These roles added to her experience in leading engineering organisations within the healthcare ecosystem and managing increasingly complex technology responsibilities. Earlier in her career, Raya spent more than a decade with the Robert Bosch Research and Technology Center. She worked initially as a Software Engineer before progressing to Senior Research Engineer, a position she held for more than seven years. This foundation in software engineering and research, followed by leadership roles across healthcare technology and product engineering, has shaped a career spanning technical innovation and large-scale engineering management. At Syneos Health, Raya joins at a time when the company is expanding the role of AI and technology across its operations. Her mandate will center on strengthening the engineering capabilities supporting this strategy, bringing together AI, engineering and technology delivery to improve agility, precision and intelligence in addressing customer challenges. She is an alumna of the Birla Institute of Technology and Science, Pilani (BITS Pilani). Syneos Health is a fully integrated biopharmaceutical solutions organisation focused on accelerating customer success. The company combines clinical, commercial and real-world insights to help address evolving market needs and support the delivery of therapies to patients. Its professionals bring together knowledge of patient and physician behaviours, market dynamics, technology and advanced business practices. Syneos Health positions technology and cross-functional expertise as important enablers in helping customers advance the development and commercialisation of therapies.
Syneos Health expands AI ecosystem with three new platform partnerships. New collaborations with Causaly, Databricks, and Microsoft anchor a broader push to embed artificial intelligence directly into clinical trial decision-making and operational workflows. "When technology is applied precisely at critical decision points, teams can anticipate risk earlier to accelerate development." Syneos Health has announced the continued expansion of its artificial intelligence (AI) ecosystem, detailing three platform partnerships designed to embed AI into core clinical development workflows.[1] The three partnerships each target a distinct layer of the clinical development stack. Through a new collaboration with Causaly, Syneos is applying agentic, evidence-based scientific reasoning to accelerate protocol strategy development, feasibility planning, and competitive trial intelligence. Causaly's platform surfaces evidence from a proprietary knowledge graph combining biomedical research and commercial insights. According to the company, the integration has reduced the time it takes to derive insights for study strategy and design by approximately 50%. The partnership with Databricks focuses on the data infrastructure layer. By leveraging the Databricks Data and AI Platform, Syneos has developed a near real-time view of clinical operations that reduces the time from source data capture to review-ready insight from days to hours, enabling faster intervention and more efficient trial execution. The Microsoft collaboration, which builds on a relationship that began in 2023, extends AI adoption through productivity and workflow tools. Syneos has used Microsoft Power Apps and other tools to develop more than 280 agents that integrate with Microsoft 365 Copilot to streamline workflows and support faster decision-making across the organization. "When technology is applied precisely at critical decision points, teams can anticipate risk earlier to accelerate development," said Mike Montello, chief digital and information officer at Syneos Health, in a company press release. Together, the three partnerships are designed to create what Syneos Health describes as a unified intelligence environment - connecting operational, clinical, and real-world data across the development lifecycle. The company noted that all capabilities are deployed with human oversight and governance to ensure responsible use in regulated environments. A broader conversation about AI and site readiness. The Syneos announcement reflects a pattern Applied Clinical Trials has been tracking closely: sponsor investment in AI is accelerating, but questions about how that technology reaches sites - and whether it actually fits their workflows - remain unresolved. In a recent with ACT, Liz Beatty, co-founder and chief strategy officer at Inato, addressed that tension directly.[2] Beatty argued that the industry has consistently made the mistake of building technology for sponsors rather than for sites. "We need to stop, and instead think: how can I enable sites to use this technology to become more efficient and effective in clinical trials, which then helps my trial and my company - not the other way around," she said. On where AI is delivering measurable enrollment impact, Beatty pointed to real-time patient data as the most significant shift. Rather than relying on feasibility questionnaires and sponsor-discounted estimates, AI tools can now identify which specific patients at a given site currently meet study criteria. In a chronic obstructive pulmonary disease case study, than those that did not, and 100% of sites using the tool were able to successfully screen and enroll patients. Looking ahead, Beatty pointed to a structural shift she sees gaining momentum: sponsors moving away from trial-by-trial site planning toward program or cross-asset planning, building deeper site partnerships across multiple studies. This represents a dynamic that could meaningfully change how enrollment bottlenecks are addressed before a trial even begins. References
Syneos Health advances ai-powered clinical ecosystem to optimize trial performance and speed decision-making. Expanding set of partners and proprietary insights strengthens operational performance. MORRISVILLE, N.C., Aug. 18, 2026 (GLOBE NEWSWIRE) - Syneos Health(R), a leading fully integrated biopharmaceutical solutions organization, today announced the continued advancement of its AI ecosystem - a unified, enterprise approach that embeds artificial intelligence (AI) directly into the core of clinical development. By combining deep therapeutic expertise, healthcare professional intelligence and modern AI technologies, Syneos Health is helping sponsors navigate an increasingly complex development landscape. Grounded in decades of clinical and commercial experience, Syneos Health's differentiated AI approach focuses on integrating advanced capabilities into critical decision points across protocol design, feasibility, enrollment planning, site activation, monitoring and operational oversight. This enables teams to anticipate risk earlier, reduce friction across workflows and make faster, more informed decisions that improve study performance. "Our priority is AI that works inside the complexity of clinical trials. By combining advanced AI with a deep understanding of sites, physicians, patients and the operational dynamics that shape trial performance, we're unlocking new opportunities for speed, clarity and quality," said Mike Montello, Chief Digital and Information Officer, Syneos Health. "When technology is applied precisely at critical decision points, teams can anticipate risk earlier to accelerate development." Enterprise AI and Data Platforms Syneos Health is building a future ready ecosystem bringing together capabilities combining scientific expertise, connected data and evidence, and AI-enabled execution. This integrated approach creates a unified intelligence environment that enables faster, more informed decisions across the clinical development lifecycle. * Causaly - Syneos Health's new collaboration with Causaly applies agentic, evidence-based scientific reasoning to enable faster protocol strategy development, feasibility planning and competitive trial intelligence. Built specifically for the life sciences sector, Causaly's Agentic Research surfaces evidence from a proprietary knowledge graph combining biomedical research and commercial insights. By accelerating analysis of complex biomedical literature and emerging data, Syneos Health teams have reduced the time it takes to derive insights for study strategy and design by approximately 50%. * Databricks - Using Databricks enables Syneos Health to create a more powerful, unified intelligence environment that brings together operational, clinical and real-world data to advance modern clinical development. Leveraging the Databricks Data + AI Platform, Syneos Health has developed a continuous, near real-time view of clinical operations that reduces the time from source data capture to review-ready insight from days to hours, enabling faster intervention and more efficient trial execution. * Microsoft - Building on its long-standing collaboration that began in 2023, Syneos Health is driving AI adoption through its integration with Microsoft. Specifically, Syneos Health has used Microsoft Power Apps and other tools to develop more than 280 agents that integrate with Microsoft 365 Copilot to improve productivity, streamline workflows and support faster, more confident decision-making across the company. Complementing these foundational capabilities are frontier agentic AI solutions and proprietary Syneos Health insights embedded directly within clinical workflows. Together, they help improve predictability, reduce operational complexity, and drive more precise, scalable trial performance. These capabilities are deployed with strong human oversight and governance, ensuring responsible use in regulated environments. "What differentiates Syneos Health is our ability to redesign how clinical development decisions are made through the combination of scientific intelligence, connected evidence, operational expertise and AI-enabled execution across the development lifecycle," said Michael Brooks, Chief Operating Officer, Syneos Health. "By grounding AI in deep clinical expertise and real-world experience, we help sponsors reduce complexity, make better-informed decisions and ultimately deliver better outcomes for patients." About Syneos Health Syneos Health(R) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. News Break Middle East translate unique clinical, commercial and real world insights into outcomes to address modern market realities. News Break Middle East bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together News Break Middle East share diverse insights, use the latest technologies and apply advanced business practices to speed its customers' delivery of important therapies to patients. Syneos Health is powered by an authentic, inclusive and high-performance culture that cares for colleagues, customers, patients, communities and the environment. Press/Media Contact: Meg Byers Director, External Communications [email protected] Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. News Break Middle East do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.